Skip to main content

Cerebral board to replace CEO amid federal probe into prescription practices

By The Wall Street Journal  
   May 18, 2022

Directors who control the board plan to install the mental-health startup's CMO in place of co-founder Kyle Robertson.

Full story


Get the latest on healthcare leadership in your inbox.